Search results for: 'tool chain'

30 Jan 2017  |  Global  |  Market Research

The Global Network Firewall Market

The Expanding Role of Firewall Sustains Market Growth

Infographics

×

The network firewall is one of the original network security tools and remains one of the most important tools used by IT organizations of all sizes. The firewall has evolved rapidly in recent years in response to the emergence of sophisticated and always changing threats. Unified threat management (UTM) and next generation firewall (NGFW) are two ...

Chemicals is a highly regulated industry, and it serves as the backbone of several other end-user sectors, including construction, transportation, healthcare, pharmaceuticals, and agriculture. Although the industry is a leading revenue generator, globally, digitalization, product portfolio diversification, enriched social responsibility, and sustai...

13 Oct 2021  |  North America  |  Market Research

Digital Customer Journey Analytics Provide a Hyper Personalized Customer Experience

Enhancing ROI, Margin, Conversion, Branding, and Differentiation in Digital-born Businesses

Infographics

×

Digital customer journey analytics refers to capturing, aggregating, and analyzing customer data (e.g., frequency of online purchases) on digital channels that allow businesses to understand customers better, improve their experience, and make interactions more meaningful. Digital analytics tools provide organizations with the opportunity to gain a...

AI generative design technology is emerging as a transformative tool across various industries, including the automotive sector. The technology tool presents tremendous potential for innovation in automotive design by enabling OEMs to explore multiple design iterations swiftly and cost-effectively to produce more fuel-efficient, lightweight vehicle...

16 Jun 2021  |  Asia Pacific  |  Market Research

Australia Firefighting Solutions Growth Opportunities

Unprecedented Scale of Australia Bushfires Necessitates Disruptive Technologies and Alignment of Regulatory Policies to Improve Outcomes

Infographics

×

Australia encountered the most devastating bushfire in its history from July 2019 to March 2020, known as the Black Summer. By the week ending December 24, 2019, the country recorded its hottest week and the hottest December. The bushfire destroyed 21% of Australian forest (except in Tasmania) and resulted in an estimated loss of A$4.5 billion in ...

Investments in CX are Accelerating to Tackle COVID-19 Challenges in the Manufacturing Industry Businesses are often unable to keep up with the expectations of today’s sophisticated customers. Competition is a click away in this digital world, and social media can make or break a business. To compete in this environment, both B2C and B2B organizatio...

30 Jul 2019  |  Global  |  Megatrends

Data Monetization, Forecast 2018–2022

Powering Innovation Through Data Monetization

Infographics

×

An increasing number of companies are starting to build data-driven strategies to fuel growth in the upcoming data economy. Though in its nascent stages, data monetization is having a huge effect on many industry verticals. Every company will, at some stage, transform into a data company through direct or indirect approaches. However, there is a la...

This research service analyzes the global trends in stationary CMM that was witnessing steady growth with demand predominantly from automotive and aerospace industries. Disruption caused by the onset of the COVID-19 pandemic resulted in demand contraction across these industries. The economic uncertainty resulted in customers being cautious about t...

25 Apr 2022  |  North America  |  Frost Radar

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...